B-cell Lymphocyte Count (Peripheral Blood)
This test measures the number of B-cells, a type of white blood cell important for producing antibodies that help fight infections and diseases like cancer.
["Understanding your B-cell count can help assess immune function and certain blood disorders."]
Key facts at a glance
- LOINC
- 40883-1
- Short code
- CD19CD103BM
- Synonyms
- CD19+CD103+ Cells NFr Mar
- Category
- chemistry
- Sample
- serum
- Container
- Heparinized bone marrow aspirate in sterile tube (sodium heparin or lithium heparin); EDTA may be acceptable for immunophenotyping panels
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Flow cytometry immunophenotyping
- CPT
- 88184
- SNOMED
- 40910005
- Specimen volume
- 1-3 mL of bone marrow aspirate; minimum 0.5 mL acceptable for pediatric samples
- Stability
- Specimen should be processed within 24 hours of collection when stored at room temperature (18-25°C). Do not refrigerate. Viability of cells decreases significantly after 48 hours.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
Why This Test Is Done
Doctors may order a B-cell count to evaluate immune system health, diagnose conditions like chronic lymphocytic leukemia (CLL), or monitor treatment responses in cancers or autoimmune diseases. It can also help check for infections or other blood disorders.
What to Expect Before the Test
No special preparation is needed. You’ll have a small needle inserted into a vein, usually in your arm, to draw a blood sample. The process is quick and typically painless.
What the Results Mean
Results show the number of B-cells in your blood. Lower than expected counts may indicate immune deficiencies or certain cancers, while higher counts could suggest overactive immune responses or other conditions. Your doctor will interpret these results in the context of your overall health.
Common Conditions Monitored
This test is often used to monitor conditions like chronic lymphocytic leukemia, autoimmune diseases (e.g., rheumatoid arthritis), or to check immune function before or after treatments like chemotherapy.
Reference range
Reference ranges are laboratory-specific and depend on the percentage of total lymphocytes or bone marrow mononuclear cells analyzed. CD19+CD103+ cells are typically rare in normal bone marrow. Results are interpreted in conjunction with clinical findings and other immunophenotypic markers.N/A
No special patient preparation is required. Patient should follow standard pre-procedural instructions for bone marrow aspiration, including informed consent. Recent chemotherapy, immunotherapy, or immunosuppressive therapy may affect results and should be documented.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical significance: Abnormal B-cell counts can signal underlying health issues, such as immune system disorders, infections, or cancers. High or low counts may require further testing or adjustments to treatment plans.
Short name
B-Cell Count
Frequently asked questions
What does a low B-cell count mean?
How often should I get this test?
Can diet or supplements affect B-cell counts?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy